Search

Your search keyword '"Northcott, Paul A"' showing total 1,124 results

Search Constraints

Start Over You searched for: Author "Northcott, Paul A" Remove constraint Author: "Northcott, Paul A"
1,124 results on '"Northcott, Paul A"'

Search Results

153. Risk stratification of childhood medulloblastoma in the molecular era: the current consensus

154. Active medulloblastoma enhancers reveal subgroup-specific cellular origins

156. Combination of Ribociclib and Gemcitabine for the Treatment of Medulloblastoma

157. MEDB-78. Unified rhombic lip origins of Group 3 and Group 4 medulloblastoma

159. ETMR-14. The single-cell landscape of pineoblastoma identifies developmental origins and exposes novel therapeutic vulnerabilities.

161. MEDB-42. GermlineElp1 deficiency promotes genomic instability and survival of granule neuron progenitors primed for SHH medulloblastoma pathogenesis

162. MEDB-49. Relapsed SHH medulloblastomas in young children. Are there alternatives to full-dose craniospinal irradiation?

164. MEDB-74. Serial assessment of measurable residual disease in medulloblastoma liquid biopsies

165. MEDB-69. Clinical and molecular meta-analysis of three major medulloblastoma clinical trials (ACNS0331, SJMB03, ACNS0332) uncovers novel strategies to improve risk-stratified therapy

166. Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis

167. The RNA-Binding Protein Musashi1 Affects Medulloblastoma Growth via a Network of Cancer-Related Genes and Is an Indicator of Poor Prognosis

169. Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers

170. Medulloblastoma subgroups remain stable across primary and metastatic compartments

173. An Animal Model of MYC-Driven Medulloblastoma

174. Author Correction: scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapy

175. The Genetic Landscape of the Childhood Cancer Medulloblastoma

176. Bridging Courses by Distance Education for Overseas-Trained Professionals Migrating to Australia: Practical and Viability Issues.

178. Delineation of Two Clinically and Molecularly Distinct Subgroups of Posterior Fossa Ependymoma

180. Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC-026)

181. Mapping pediatric brain tumors to their origins in the developing cerebellum

182. Revised clinical and molecular risk strata define the incidence and pattern of failure in medulloblastoma following risk-adapted radiotherapy and dose-intensive chemotherapy: results from a phase III multi-institutional study

183. Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity

185. Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort

186. Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group

187. Divergent clonal selection dominates medulloblastoma at recurrence

189. Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system

190. TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma

191. BIOM-36. SERIAL ASSESSMENT OF MEASURABLE RESIDUAL DISEASE IN MEDULLOBLASTOMA LIQUID BIOPSIES

192. EPCO-26. INTEGRATIVE MULTI-OMICS IDENTIFIES CONVERGING DEVELOPMENTAL ORIGINS OF DISTINCT MEDULLOBLASTOMA SUBGROUPS

193. Serial assessment of measurable residual disease in medulloblastoma liquid biopsies

194. Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma

195. DNA methylation-based classification of central nervous system tumours

196. The landscape of genomic alterations across childhood cancers

197. Author Correction: The landscape of genomic alterations across childhood cancers

199. Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays

200. Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma

Catalog

Books, media, physical & digital resources